Advances in Anatomic Pathology

Papers
(The H4-Index of Advances in Anatomic Pathology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The Social Media Paradox: Unravelling the Impact of Digital Networks on Pathology55
Controversial and Evolving Issues in Gynecologic Pathology42
The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review27
Do We Have Sufficient Evidence to Define Prognosis for “Low-grade” Fumarate Hydratase–deficient Renal Cell Carcinoma?26
SWI/SNF-deficient Sinonasal Carcinomas23
Update on the Use of Molecular Subtyping in Breast Cancer22
Artificial Intelligence and Lung Pathology21
Role of Surgical Pathologist for the Detection of Immuno-oncologic Predictive Factors in Non-small Cell Lung Cancers20
Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making19
Rare Liver Diseases With Near-Normal Histology: A Review Focusing on Metabolic, Storage, and Inclusion Disorders17
Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions16
The Significance of Recognition of Human Epidermal Growth Factor 2 Low in Breast Cancer Therapy15
Mesothelioma: A Tumor of Ubiquitous Distribution15
Selected Case From the Arkadi M. Rywlin International Pathology Slide Seminar: Involvement of Skin and Soft Tissue by Erdheim-Chester Disease15
Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior14
The “Other” Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities14
The Role of The Surgical Pathologist in the Recognition of Hereditary Gynecologic Cancer14
Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing14
Uterine Smooth Muscle Tumors: An Overview14
0.037189960479736